F5 Networks (FFIV) Soars on a Strong FQ3 Beat, Analysts Raise PTs

F5 Networks (FFIV) PT Raised to $264 at Cowen

Cowen analyst Paul Silverstein raised the price target on F5 Networks (NASDAQ: FFIV) to $264.00 (from $252.00) while maintaining an Outperform rating.

The analyst commented, "FFIV delivered strong FY3Q21 results against a backdrop of muted to outright negative expectations. Strong broad-based underlying demand trends,... More

F5 Networks (FFIV) PT Raised to $265 at Needham & Company

Needham & Company analyst Alex Henderson raised the price target on F5 Networks (NASDAQ: FFIV) to $265.00 (from $255.00) while maintaining a Buy rating following results.

The analyst commented, "F5 sounded very confident on its 3QF21 earnings call, and its stock appreciated over the... More

F5 Networks (FFIV) PT Raised to $238 at Credit Suisse

Credit Suisse analyst Sami Badri raised the price target on F5 Networks (NASDAQ: FFIV) to $238.00 (from $235.00) while maintaining a Outperform rating.... More

F5 Networks (FFIV) PT Raised to $215 at RBC Capital

RBC Capital analyst Matthew Hedberg raised the price target on F5 Networks (NASDAQ: FFIV) to $215.00 (from $200.00) while maintaining a Sector Perform rating.... More

F5 Networks (FFIV) PT Raised to $234 at Barclays

Barclays analyst Tim Long raised the price target on F5 Networks (NASDAQ: FFIV) to $234.00 (from $233.00) while maintaining a Overweight rating.... More

After-Hours Stock Movers 07/26: (CERC) (UHS) (FFIV) Higher; (BTBT) (MINM) (TDUP) Lower (more...)

After-Hours Stock Movers:

Cerecor Inc. (NASDAQ: CERC) 14.4% HIGHER; announced positive initial results from a Phase 1b proof-of-concept study evaluating CERC-002, an investigational first-in-class fully human anti-LIGHT (tumor necrosis factor superfamily member 14 (TNFSF14)) monoclonal antibody, in adult patients with moderate to severe Crohn's disease (CD). Crohns disease is a disorder affecting as many as 780,000 people in the United States.

Bit Digital, Inc. (NASDAQ: BTBT) 13.3% LOWER; gained 110% intra-day on move higher... More

F5 Networks (FFIV) Tops Q3 EPS by 30c, Offers Q4 Guidance

F5 Networks (NASDAQ: FFIV) reported Q3 EPS of $2.76, $0.30 better than the analyst estimate of $2.46. Revenue for the quarter came in at $652 million versus the consensus estimate of $638.14 million.

GUIDANCE:

F5 Networks sees Q4 2021 EPS of $2.68-$2.80, versus the consensus of... More